-
公开(公告)号:US12029752B2
公开(公告)日:2024-07-09
申请号:US16484002
申请日:2015-07-06
发明人: Ajay Nilawar
IPC分类号: A61K31/718 , A23L29/219 , A23L29/238 , A23L33/00 , A23L33/21 , A61K31/716 , A61K31/721 , A61K31/736 , A61K45/06 , A61P1/00 , A61P1/10 , A61P3/00 , A61P3/06 , A61P3/10
CPC分类号: A61K31/718 , A23L29/219 , A23L29/238 , A23L33/21 , A23L33/30 , A61K31/716 , A61K31/721 , A61K31/736 , A61K45/06 , A61P1/00 , A61P1/10 , A61P3/00 , A61P3/06 , A61P3/10
摘要: A water soluble dietary fibre composition and use thereof is disclosed. The composition comprises: (a) partially hydrolysed and re-polymerized starch, and (b) partially hydrolysed Guar gum.
-
公开(公告)号:US12023350B2
公开(公告)日:2024-07-02
申请号:US17706270
申请日:2022-03-28
发明人: Marc Washington , Ren-Hau Lai , Mengyu Zhao
IPC分类号: A61K31/718 , A23L33/115 , A23L33/185 , A23L33/22 , A61K9/00 , A61K38/00
CPC分类号: A61K31/718 , A23L33/115 , A23L33/185 , A23L33/22 , A61K9/0056 , A61K38/00 , A23V2002/00
摘要: A health benefiting daily nutrition includes protein, the protein having a protein weight. The health benefiting daily nutrition includes fiber, the fiber having a fiber weight. The fiber weight is more than 5 g. A ratio of [the protein weight]:[the fiber weight]=1:0.5-1.5.
-
公开(公告)号:US20240041944A1
公开(公告)日:2024-02-08
申请号:US18181504
申请日:2023-03-09
申请人: ISOThrive LLC
发明人: Lee Madsen, II , Jack Oswald , Sarah Stanley
IPC分类号: A61K35/66 , A61K31/702 , A61K31/732 , A61K31/733 , A61P1/00 , A61P3/00 , A61P35/00 , A61P5/00 , C12Q1/689 , A61K35/744 , A61K31/717 , A61K31/715 , A61K31/718 , A61K31/736 , C12Q1/04 , C12Q1/68
CPC分类号: A61K35/66 , A61K31/702 , A61K31/732 , A61K31/733 , A61P1/00 , A61P3/00 , A61P35/00 , A61P5/00 , C12Q1/689 , A61K35/744 , A61K31/717 , A61K31/715 , A61K31/718 , A61K31/736 , C12Q1/04 , C12Q1/68
摘要: Methods are described herein for identifying and providing prebiotic compositions that are optimized for the health needs of individuals.
-
公开(公告)号:US11857553B2
公开(公告)日:2024-01-02
申请号:US16366936
申请日:2019-03-27
申请人: NUTRITION 21, LLC
发明人: James R. Komorowski
IPC分类号: A61K31/555 , A61K31/718 , A61K33/24 , A23L33/165 , A23L33/17 , A23L33/125 , A23L33/16 , A61K9/08 , A61K9/14 , A61K31/198 , A61K31/732 , A61K36/899 , A61K38/01 , A61K45/06
CPC分类号: A61K31/555 , A23L33/125 , A23L33/16 , A23L33/165 , A23L33/17 , A61K9/08 , A61K9/14 , A61K31/198 , A61K31/718 , A61K31/732 , A61K33/24 , A61K36/899 , A61K38/018 , A61K45/06 , A23V2002/00 , A61K31/718 , A61K2300/00 , A61K31/555 , A61K2300/00
摘要: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
-
公开(公告)号:US11617764B2
公开(公告)日:2023-04-04
申请号:US16018582
申请日:2018-06-26
IPC分类号: A61K33/14 , A61K31/718 , A61M1/28 , A61J1/20 , A61J1/10
摘要: The present invention is a sterile peritoneal dialysis fluid, including an acidic first liquid containing 60.0 to 94.0 g/L of icodextrin and 0 to 2.34 g/L of sodium chloride, and an alkaline second liquid containing an alkaline pH regulator, in which the first liquid after sterilization has a pH of 5.0 to 5.5, the second liquid after sterilization has a pH of 6.5 to 7.5, and a mixture of the first liquid and the second liquid after sterilization has a pH of 6.0 to 7.5. The present invention can provide a peritoneal dialysis fluid containing icodextrin, in which the stability of icodextrin during the heat sterilization and the subsequent storage can be improved to the maximum, and the pH of the peritoneal dialysis fluid is close to the physiological range.
-
公开(公告)号:US11603546B2
公开(公告)日:2023-03-14
申请号:US16934195
申请日:2020-07-21
摘要: Disclosed herein are methods for preparing modified starches, and uses thereof, and relates to the technical field of starch preparation; modifying a gelatinized starch suspension with β-amylase; after inactivating the β-amylase, further modifying with a branching enzyme, after inactivating the branching enzyme, further modifying with pullulanase, after inactivating the pullulanase, precipitating a resulting enzymatic hydrolysate with an alcohol to obtain precipitates; and drying the precipitates to obtain the modified starch. The methods disclosed a starch is modified remarkably, herein substantially increase the number of linear chains with a degree of polymerization DP6-11 in the starch chains and, thus, significantly increase the content of resistant starch in the modified starch—thereby facilitating the use in foods and medicaments.
-
公开(公告)号:US11590097B2
公开(公告)日:2023-02-28
申请号:US16389272
申请日:2019-04-19
发明人: Peter Geisser , Erik Philipp , Walter Richie
IPC分类号: A61K31/295 , A61P7/06 , A61K31/718 , A61K33/26 , A61K47/61 , A61K45/06 , C08B31/18 , C08B30/18 , C08B37/00
摘要: A water soluble iron carbohydrate complex obtainable from an aqueous solution of iron (III) salt and an aqueous solution of the oxidation product of one or more maltodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, process for its production and a medicament for the treatment and prophylaxis of iron deficiency conditions.
-
公开(公告)号:US20230017911A1
公开(公告)日:2023-01-19
申请号:US17828758
申请日:2022-05-31
IPC分类号: A61K31/716 , A61K31/718 , A61P25/28 , A61P25/00
摘要: The invention relates to compositions and methods of treating a sleep-wake disorder or neurodegenerative diseases using modified resistant maltodextrin.
-
公开(公告)号:US20220288126A1
公开(公告)日:2022-09-15
申请号:US17828573
申请日:2022-05-31
申请人: Jeffrey M. Golini
发明人: Jeffrey M. Golini
IPC分类号: A61K35/20 , A23L5/00 , A23L33/125 , A61K31/198 , A61K31/337 , A61K36/185 , A61K36/90 , A61K45/06 , A23L29/30 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/175 , A23L33/00 , A23L33/16 , A23L33/185 , A23L33/19 , A61K36/889 , A61K31/718 , A61K33/00 , A61K33/42 , A61K31/661 , A61K36/899 , A61K38/16
摘要: The invention relates to a pharmaceutical or nutraceutical composition comprising an alkalized organic substance selected from the group comprising proteins, carbohydrates, lipids, amino acids, vitamins, therapeutic agents and mixtures thereof. Such compositions are useful for treating a range of diseases and conditions. They also give rise to beneficial physiological effects such as, for example, increasing physical strength, muscle mass and endurance.
-
公开(公告)号:US20220288125A1
公开(公告)日:2022-09-15
申请号:US17684861
申请日:2022-03-02
发明人: Lara Nyman
IPC分类号: A61K35/20 , A61K31/405 , A61K31/4172 , A61K31/198 , A61K31/718 , A61K31/7076 , A61K9/00 , A61P25/20
摘要: A nutritional composition that includes from about 75% to about 95% of a first protein source that includes from about 85% to about 99% of protein by weight of the first protein source to provide an endogenous source of tryptophan in an amount between about 1% to about 6% of tryptophan by weight of the first protein source; and from about 0.5% to about 2% of a second protein source by weight of the nutritional composition, the second protein source consisting of an exogenous source of tryptophan such that the nutritional composition provides a ratio of tryptophan to large neutral amino acids in the range from about 0.080:1 to about 0.167:1.
-
-
-
-
-
-
-
-
-